Loading…
Sectoral / Thematic · quant Mutual Fund · AMFI code 151853quant Healthcare Fund
Disclosed for 38 months, Aug 2023 to Sep 2026.
Portfolio value
₹425 Cr
up ₹8.3 Cr vs May 2025
- Stocks held
- 15
- unchanged
- Top 10 weight
- 71.5%
- of the portfolio in its ten largest
- Cash & debt
- 3.2%
- cash, money market and debt
quant Healthcare Fund is an active equity fund in the Sectoral / Thematic category from quant Mutual Fund. In June 2025 it disclosed 15 stocks worth ₹425 Cr, up ₹8.3 Cr from May 2025. Its largest positions were Divi's Laboratories Limited (10.0%), Aster DM Healthcare Limited (9.9%), RPG Life Sciences Limited (8.8%); the ten largest together made up 71.5% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 63.3% of its equity. Cash and debt stood at 3.2%. Compared with May 2025 the fund entered 0 new stocks and exited 0.
Against 229 other Sectoral / Thematic funds
Concentration
94%
Top-10 weight is higher than 94% of peers
Breadth
2%
Holds more stocks than 2% of peers
Cash
46%
Holds more cash than 46% of peers
What these mean: concentration · cash
Holdings in June 2025
Download CSVEvery line the fund disclosed, with the change against May 2025. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Divi's Laboratories Limited | 9.99% | up 0.10 pts | ₹42.5 Cr | up ₹1.2 Cr | Added |
| Aster DM Healthcare Limited | 9.88% | up 0.42 pts | ₹42 Cr | up ₹2.6 Cr | Added |
| RPG Life Sciences Limited | 8.78% | up 0.91 pts | ₹37.3 Cr | up ₹4.5 Cr | Added |
| Sequent Scientific Limited | 6.69% | down 0.10 pts | ₹28.5 Cr | up ₹13 L | Held |
| Pfizer Limited | 6.44% | down 0.05 pts | ₹27.4 Cr | up ₹31 L | Added |
| Zydus Wellness Limited | 6.11% | up 0.11 pts | ₹26 Cr | up ₹95 L | Added |
| Lupin Limited 31/07/2025 Derivative | 6.00% | up 6.00 pts | ₹25.5 Cr | up ₹25.5 Cr | New |
| HDFC Life Insurance Company Limited | 5.97% | up 0.16 pts | ₹25.4 Cr | up ₹1.2 Cr | Added |
| Glenmark Life Sciences Limited | 5.82% | down 0.32 pts | ₹24.8 Cr | down ₹87 L | Trimmed |
| Aurobindo Pharma Limited | 5.80% | down 0.18 pts | ₹24.7 Cr | down ₹28 L | Trimmed |
| SMS Pharmaceuticals Limited | 4.91% | down 0.38 pts | ₹20.9 Cr | down ₹1.2 Cr | Trimmed |
| HFCL Limited | 4.86% | down 0.16 pts | ₹20.7 Cr | down ₹25 L | Trimmed |
| Sun Pharmaceutical Industries Limited | 3.04% | down 0.06 pts | ₹12.9 Cr | down ₹1 L | Held |
| Laxmi Dental Limited | 2.96% | up 2.46 pts | ₹12.6 Cr | up ₹10.5 Cr | Added |
| Sun Pharmaceutical Industries Limited 31/07/2025 Derivative | 2.88% | up 2.88 pts | ₹12.2 Cr | up ₹12.2 Cr | New |
| Lupin Limited | 2.60% | down 0.08 pts | ₹11 Cr | down ₹11 L | Trimmed |
| Aurobindo Pharma Limited 31/07/2025 Derivative | 2.51% | up 2.51 pts | ₹10.7 Cr | up ₹10.7 Cr | New |
| Suraksha Diagnostic Limited | 1.57% | down 1.03 pts | ₹6.7 Cr | down ₹4.1 Cr | Trimmed |
| 91 Days Treasury Bill 17-Jul-2025 Debt | 1.17% | down 0.02 pts | ₹5 Cr | up ₹2 L | Held |
| 91 Days Treasury Bill 21-Aug-2025 Debt | 1.17% | down 0.02 pts | ₹5 Cr | up ₹2 L | Added |
| 91 Days Treasury Bill 18-Sep-2025 Debt | 0.93% | up 0.93 pts | ₹4 Cr | up ₹4 Cr | New |
| 91 Days Treasury Bill 28-Aug-2025 Debt | 0.70% | down 0.01 pts | ₹3 Cr | up ₹2 L | Added |
| 91 Days Treasury Bill 25-Sep-2025 Debt | 0.70% | up 0.70 pts | ₹3 Cr | up ₹3 Cr | New |
| 91 Days Treasury Bill 11-Sep-2025 Debt | 0.47% | up 0.47 pts | ₹2 Cr | up ₹2 Cr | New |
| 182 Days Treasury Bill 04-Sep-2025 Debt | 0.23% | up 0.23 pts | ₹99 L | up ₹99 L | New |
| 91 Days Treasury Bill 04-Sep-2025 Debt | 0.23% | up 0.23 pts | ₹99 L | up ₹99 L | New |
| Cash, TREPS & receivables | −2.40% | up 0.48 pts | −₹10.2 Cr | up ₹1.8 Cr | Added |
What changed, May 2025 to Jun 2025
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Laxmi Dental Limitedup ₹10.5 Cr (+2.46% pts)
- RPG Life Sciences Limitedup ₹4.5 Cr (+0.91% pts)
- Aster DM Healthcare Limitedup ₹2.6 Cr (+0.42% pts)
- Divi's Laboratories Limitedup ₹1.2 Cr (+0.10% pts)
- HDFC Life Insurance Company Limited ₹1.2 Cr (+0.16% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since May 2025, the weight rose most in Healthcare Equipment & Supplies (+2.9 pts), and fell most in Pharmaceuticals & Biotechnology (−1.6 pts) and Healthcare Services (−1.0 pts).
- Healthcare Equipment & Supplies0.6% → 3.5%+2.9 pts
- Pharmaceuticals & Biotechnology64.9% → 63.3%−1.6 pts
- Healthcare Services14.4% → 13.4%−1.0 pts
- Telecom - Services6.0% → 5.7%−0.3 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Jun 2024 | Dec 2024 | Mar 2025 | May 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 71.0% | 66.1% | 70.1% | 64.9% | 63.3% |
| Healthcare Services | 18.9% | 15.1% | 11.9% | 14.4% | 13.4% |
| Food Products | — | 6.0% | 6.0% | 7.2% | 7.1% |
| Insurance | — | — | — | 6.9% | 7.0% |
| Telecom - Services | — | 6.4% | 5.2% | 6.0% | 5.7% |
| Healthcare Equipment & Supplies | 10.1% | — | — | 0.6% | 3.5% |
Allocation in Jun 2025change vs May 2025
- Pharmaceuticals & Biotechnology (9)63.3%▼ 1.6 pts
- Healthcare Services (2)13.4%▼ 1.0 pts
- Food Products (1)7.1%
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Jun 2025
3.2%
▲ 3.0 pts vs May 2025
- Cash alone
- −2.4%
- cash and net receivables
- A year earlier
- 2.6%
- Jun 2024 · now ▲ 0.6 pts
- Last 12 months
- 0.2% – 7.0%
- lowest to highest · record 7.5% in Feb 2024
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.